TECNIS 3-Piece Multifocal, Model ZMA00
Johnson & Johnson Surgical Vision, Inc. · Decision date Jun 3, 2026
What did the FDA decide?
FDA records P080010/S031 as a supplement to PMA P080010, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jun 3, 2026.
FDA approval order statement
an alternative supplier for the edge blockers for the 3-piece IOLs (AR40e, AR40E, AR40M, AR40MN, ZMA00, and ZA9003)
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Jun 3, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P080010/S031
- Regulatory pathway
- PMA supplement
- Product code
- MFK
- Decision code
- OK30
- Decision date
- Jun 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lens, multifocal intraocular.
- Product code
- MFK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P080010. Subsequent supplements may change the device or its indications.
FDA decision timeline
P080010 · Original PMA
TECNIS MULTIFOCAL FOLDABLE POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)
P080010/S028 · Related supplement
TECNIS 3-Piece Multifocal, Model ZMA00
P080010/S029 · Related supplement
TECNIS 3-Piece Multifocal, Model ZMA00
P080010/S027 · Related supplement
TECNIS Multifocal 3-Piece IOL
P080010/S030 · Related supplement
TECNIS Multi-focal 3-pc, ZMA00
P080010/S031 received
Application receipt date recorded by FDA.
P080010/S031 · FDA decision
30-Day Notice
P080010/S032 · Related supplement
TECNIS Multi-focal 3-pc, Model ZMA00
Timeline entries are records held by MedtechLedger for P080010. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P080010
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | PMA approval | Jan 16, 2009 | FDA | |
TECNIS 3-Piece Multifocal, Model ZMA00P080010/S028 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Jul 22, 2025 | FDA |
TECNIS 3-Piece Multifocal, Model ZMA00P080010/S029 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Sep 2, 2025 | FDA |
TECNIS Multifocal 3-Piece IOLP080010/S027 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Sep 10, 2025 | FDA |
TECNIS Multi-focal 3-pc, ZMA00P080010/S030 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Jan 12, 2026 | FDA |
TECNIS Multi-focal 3-pc, Model ZMA00P080010/S032 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA |
Explore the linked device profile
Other records with product code MFK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ClearView HD intraocular lens (IOL)P200020/S013 | Lenstec, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA | |
| Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Bausch + Lomb, Inc. | PMA supplement | Sep 30, 2026 | FDA | |
| Rayner Intraocular Lenses , Ltd. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Johnson & Johnson Surgical Vision, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 31 Technology Dr., Suite 200, Irvine, CA, 92618
Sources and methodology
- Original FDA record: P080010/S031
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




